Global Sickle Cell Disease Therapeutics Market Growth 2018-2023

October 2018 | 163 pages | ID: G7E36A8B6EDEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.
Over the next five years, LPI(LP Information) projects that Sickle Cell Disease Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Sickle Cell Disease Therapeutics market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Sickle Cell Disease Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Sickle Cell Anemia
• Sickle Beta Thalassemia
• Sickle Hemoglobin C Disease

Segmentation by application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• AstraZeneca
• Eli Lilly
• Novartis
• Pfizer
• Baxter
• Emmaus Life Sciences
• Bluebird bio
• Blood Therapeutics
• Sangamo Therapeutics
• Acceleron Pharma
• Arena Pharmaceuticals
• Alnylam Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Sickle Cell Disease Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Sickle Cell Disease Therapeutics market by identifying its various subsegments.
• Focuses on the key global Sickle Cell Disease Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Sickle Cell Disease Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Sickle Cell Disease Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sickle Cell Disease Therapeutics Consumption 2013-2023
  2.1.2 Sickle Cell Disease Therapeutics Consumption CAGR by Region
2.2 Sickle Cell Disease Therapeutics Segment by Type
  2.2.1 Sickle Cell Anemia
  2.2.2 Sickle Beta Thalassemia
  2.2.3 Sickle Hemoglobin C Disease
2.3 Sickle Cell Disease Therapeutics Consumption by Type
  2.3.1 Global Sickle Cell Disease Therapeutics Consumption Market Share by Type (2013-2018)
  2.3.2 Global Sickle Cell Disease Therapeutics Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Sickle Cell Disease Therapeutics Sale Price by Type (2013-2018)
2.4 Sickle Cell Disease Therapeutics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Sickle Cell Disease Therapeutics Consumption by Application
  2.5.1 Global Sickle Cell Disease Therapeutics Consumption Market Share by Application (2013-2018)
  2.5.2 Global Sickle Cell Disease Therapeutics Value and Market Share by Application (2013-2018)
  2.5.3 Global Sickle Cell Disease Therapeutics Sale Price by Application (2013-2018)

3 GLOBAL SICKLE CELL DISEASE THERAPEUTICS BY PLAYERS

3.1 Global Sickle Cell Disease Therapeutics Sales Market Share by Players
  3.1.1 Global Sickle Cell Disease Therapeutics Sales by Players (2016-2018)
  3.1.2 Global Sickle Cell Disease Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Sickle Cell Disease Therapeutics Revenue Market Share by Players
  3.2.1 Global Sickle Cell Disease Therapeutics Revenue by Players (2016-2018)
  3.2.2 Global Sickle Cell Disease Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Sickle Cell Disease Therapeutics Sale Price by Players
3.4 Global Sickle Cell Disease Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Sickle Cell Disease Therapeutics Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Sickle Cell Disease Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 SICKLE CELL DISEASE THERAPEUTICS BY REGIONS

4.1 Sickle Cell Disease Therapeutics by Regions
  4.1.1 Global Sickle Cell Disease Therapeutics Consumption by Regions
  4.1.2 Global Sickle Cell Disease Therapeutics Value by Regions
4.2 Americas Sickle Cell Disease Therapeutics Consumption Growth
4.3 APAC Sickle Cell Disease Therapeutics Consumption Growth
4.4 Europe Sickle Cell Disease Therapeutics Consumption Growth
4.5 Middle East & Africa Sickle Cell Disease Therapeutics Consumption Growth

5 AMERICAS

5.1 Americas Sickle Cell Disease Therapeutics Consumption by Countries
  5.1.1 Americas Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018)
  5.1.2 Americas Sickle Cell Disease Therapeutics Value by Countries (2013-2018)
5.2 Americas Sickle Cell Disease Therapeutics Consumption by Type
5.3 Americas Sickle Cell Disease Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Sickle Cell Disease Therapeutics Consumption by Countries
  6.1.1 APAC Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018)
  6.1.2 APAC Sickle Cell Disease Therapeutics Value by Countries (2013-2018)
6.2 APAC Sickle Cell Disease Therapeutics Consumption by Type
6.3 APAC Sickle Cell Disease Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Sickle Cell Disease Therapeutics by Countries
  7.1.1 Europe Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018)
  7.1.2 Europe Sickle Cell Disease Therapeutics Value by Countries (2013-2018)
7.2 Europe Sickle Cell Disease Therapeutics Consumption by Type
7.3 Europe Sickle Cell Disease Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sickle Cell Disease Therapeutics by Countries
  8.1.1 Middle East & Africa Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Sickle Cell Disease Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Sickle Cell Disease Therapeutics Consumption by Type
8.3 Middle East & Africa Sickle Cell Disease Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Sickle Cell Disease Therapeutics Distributors
10.3 Sickle Cell Disease Therapeutics Customer

11 GLOBAL SICKLE CELL DISEASE THERAPEUTICS MARKET FORECAST

11.1 Global Sickle Cell Disease Therapeutics Consumption Forecast (2018-2023)
11.2 Global Sickle Cell Disease Therapeutics Forecast by Regions
  11.2.1 Global Sickle Cell Disease Therapeutics Forecast by Regions (2018-2023)
  11.2.2 Global Sickle Cell Disease Therapeutics Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Sickle Cell Disease Therapeutics Forecast by Type
11.8 Global Sickle Cell Disease Therapeutics Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AstraZeneca
  12.1.1 Company Details
  12.1.2 Sickle Cell Disease Therapeutics Product Offered
  12.1.3 AstraZeneca Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 AstraZeneca News
12.2 Eli Lilly
  12.2.1 Company Details
  12.2.2 Sickle Cell Disease Therapeutics Product Offered
  12.2.3 Eli Lilly Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Eli Lilly News
12.3 Novartis
  12.3.1 Company Details
  12.3.2 Sickle Cell Disease Therapeutics Product Offered
  12.3.3 Novartis Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Novartis News
12.4 Pfizer
  12.4.1 Company Details
  12.4.2 Sickle Cell Disease Therapeutics Product Offered
  12.4.3 Pfizer Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Pfizer News
12.5 Baxter
  12.5.1 Company Details
  12.5.2 Sickle Cell Disease Therapeutics Product Offered
  12.5.3 Baxter Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Baxter News
12.6 Emmaus Life Sciences
  12.6.1 Company Details
  12.6.2 Sickle Cell Disease Therapeutics Product Offered
  12.6.3 Emmaus Life Sciences Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Emmaus Life Sciences News
12.7 Bluebird bio
  12.7.1 Company Details
  12.7.2 Sickle Cell Disease Therapeutics Product Offered
  12.7.3 Bluebird bio Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Bluebird bio News
12.8 Blood Therapeutics
  12.8.1 Company Details
  12.8.2 Sickle Cell Disease Therapeutics Product Offered
  12.8.3 Blood Therapeutics Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Blood Therapeutics News
12.9 Sangamo Therapeutics
  12.9.1 Company Details
  12.9.2 Sickle Cell Disease Therapeutics Product Offered
  12.9.3 Sangamo Therapeutics Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Sangamo Therapeutics News
12.10 Acceleron Pharma
  12.10.1 Company Details
  12.10.2 Sickle Cell Disease Therapeutics Product Offered
  12.10.3 Acceleron Pharma Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Acceleron Pharma News
12.11 Arena Pharmaceuticals
12.12 Alnylam Pharmaceuticals

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sickle Cell Disease Therapeutics
Table Product Specifications of Sickle Cell Disease Therapeutics
Figure Sickle Cell Disease Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Sickle Cell Disease Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Sickle Cell Disease Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Sickle Cell Disease Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Sickle Cell Anemia
Table Major Players of Sickle Cell Anemia
Figure Product Picture of Sickle Beta Thalassemia
Table Major Players of Sickle Beta Thalassemia
Figure Product Picture of Sickle Hemoglobin C Disease
Table Major Players of Sickle Hemoglobin C Disease
Table Global Consumption Sales by Type (2013-2018)
Table Global Sickle Cell Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Sickle Cell Disease Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Sickle Cell Disease Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Sickle Cell Disease Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Sickle Cell Disease Therapeutics Value Market Share by Type (2013-2018)
Table Global Sickle Cell Disease Therapeutics Sale Price by Type (2013-2018)
Figure Sickle Cell Disease Therapeutics Consumed in Hospitals
Figure Global Sickle Cell Disease Therapeutics Market: Hospitals (2013-2018) (K Units)
Figure Global Sickle Cell Disease Therapeutics Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Sickle Cell Disease Therapeutics Consumed in Clinics
Figure Global Sickle Cell Disease Therapeutics Market: Clinics (2013-2018) (K Units)
Figure Global Sickle Cell Disease Therapeutics Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Sickle Cell Disease Therapeutics Consumed in Others
Figure Global Sickle Cell Disease Therapeutics Market: Others (2013-2018) (K Units)
Figure Global Sickle Cell Disease Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Sickle Cell Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Sickle Cell Disease Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Sickle Cell Disease Therapeutics Value by Application (2013-2018)
Table Global Sickle Cell Disease Therapeutics Value Market Share by Application (2013-2018)
Figure Global Sickle Cell Disease Therapeutics Value Market Share by Application (2013-2018)
Table Global Sickle Cell Disease Therapeutics Sale Price by Application (2013-2018)
Table Global Sickle Cell Disease Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Sickle Cell Disease Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Sickle Cell Disease Therapeutics Sales Market Share by Players in 2016
Figure Global Sickle Cell Disease Therapeutics Sales Market Share by Players in 2017
Table Global Sickle Cell Disease Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Sickle Cell Disease Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Sickle Cell Disease Therapeutics Revenue Market Share by Players in 2016
Figure Global Sickle Cell Disease Therapeutics Revenue Market Share by Players in 2017
Table Global Sickle Cell Disease Therapeutics Sale Price by Players (2016-2018)
Figure Global Sickle Cell Disease Therapeutics Sale Price by Players in 2017
Table Global Sickle Cell Disease Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Sickle Cell Disease Therapeutics Products Offered
Table Sickle Cell Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Sickle Cell Disease Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Sickle Cell Disease Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Sickle Cell Disease Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Sickle Cell Disease Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Sickle Cell Disease Therapeutics Value Market Share by Regions 2013-2018
Figure Global Sickle Cell Disease Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Sickle Cell Disease Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Sickle Cell Disease Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Sickle Cell Disease Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Sickle Cell Disease Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Sickle Cell Disease Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Sickle Cell Disease Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Value 2013-2018 ($ Millions)
Table Americas Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Sickle Cell Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Sickle Cell Disease Therapeutics Consumption Market Share by Countries in 2017
Table Americas Sickle Cell Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Sickle Cell Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Sickle Cell Disease Therapeutics Value Market Share by Countries in 2017
Table Americas Sickle Cell Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Sickle Cell Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Sickle Cell Disease Therapeutics Consumption Market Share by Type in 2017
Table Americas Sickle Cell Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Sickle Cell Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Sickle Cell Disease Therapeutics Consumption Market Share by Application in 2017
Figure United States Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Sickle Cell Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Sickle Cell Disease Therapeutics Consumption Market Share by Countries in 2017
Table APAC Sickle Cell Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Sickle Cell Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Sickle Cell Disease Therapeutics Value Market Share by Countries in 2017
Table APAC Sickle Cell Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Sickle Cell Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Sickle Cell Disease Therapeutics Consumption Market Share by Type in 2017
Table APAC Sickle Cell Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Sickle Cell Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Sickle Cell Disease Therapeutics Consumption Market Share by Application in 2017
Figure China Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Sickle Cell Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Sickle Cell Disease Therapeutics Consumption Market Share by Countries in 2017
Table Europe Sickle Cell Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Sickle Cell Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Sickle Cell Disease Therapeutics Value Market Share by Countries in 2017
Table Europe Sickle Cell Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Sickle Cell Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Sickle Cell Disease Therapeutics Consumption Market Share by Type in 2017
Table Europe Sickle Cell Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Sickle Cell Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Sickle Cell Disease Therapeutics Consumption Market Share by Application in 2017
Figure Germany Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Sickle Cell Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Sickle Cell Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Sickle Cell Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Sickle Cell Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Sickle Cell Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Sickle Cell Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Sickle Cell Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Sickle Cell Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Sickle Cell Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Sickle Cell Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table Sickle Cell Disease Therapeutics Distributors List
Table Sickle Cell Disease Therapeutics Customer List
Figure Global Sickle Cell Disease Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Sickle Cell Disease Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Sickle Cell Disease Therapeutics Consumption Market Forecast by Regions
Table Global Sickle Cell Disease Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Therapeutics Value Market Share Forecast by Regions
Figure Americas Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure United States Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure United States Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure China Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure China Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure India Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure India Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure France Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure France Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure UK Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure UK Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Sickle Cell Disease Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Sickle Cell Disease Therapeutics Value 2018-2023 ($ Millions)
Table Global Sickle Cell Disease Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Sickle Cell Disease Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Sickle Cell Disease Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Sickle Cell Disease Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Sickle Cell Disease Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Sickle Cell Disease Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Therapeutics Value Market Share Forecast by Application (2018-2023)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Baxter Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Emmaus Life Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emmaus Life Sciences Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Emmaus Life Sciences Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Bluebird bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bluebird bio Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bluebird bio Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Blood Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Blood Therapeutics Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Blood Therapeutics Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Sangamo Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sangamo Therapeutics Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sangamo Therapeutics Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Acceleron Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acceleron Pharma Sickle Cell Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Acceleron Pharma Sickle Cell Disease Therapeutics Market Share (2016-2018)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors